Chandana is a medical doctor with work, research and educational experience across European, American and Asian markets. After a stint in clinical practice in tertiary and primary care, she has engaged in leadership positions in the digital health space to bring to life market innovations that bridge gaps in healthcare. She likes to bring ideas to life by supporting young digital health businesses to become stronger players. She is currently driving global collaborations in digital health and medicine as HealthXLs CEO. HealthXL is leading the charge in connecting leaders from across the globe to solve healthcare challenges.
She enjoys being surrounded by passionate, committed & ”figure-it-out” people who push the envelope. She believes great work happens when you enjoy the journey.

Michelangelo Canzoneri, PhD, serves as the Global Head of Group Smart Manufacturing at Merck KGaA, based in Darmstadt, Germany. A seasoned leader in digital transformation, he acts as the key business interface across the Life Science, Healthcare, and Electronics sectors. His role is instrumental in steering Smart Manufacturing and Supply Chain Analytics, fostering cross-sector collaboration, and advancing innovative solutions.

In addition to his corporate responsibilities, Michelangelo is a professor at the University of Applied Sciences and Goethe Business School in Frankfurt.
He cultivates a culture of intellectual curiosity and continuous learning, preparing the next generation of industry leaders.

An advocate for technological advancement, Michelangelo promotes the integration of process analytical technologies, data analytics, and artificial intelligence as essential components for the industry’s future.

Isabelle Widmer is the founder and CEO of Elytra, a life science consulting firm based in Switzerland.

A consultant and executive coach, Isabelle has over a decade of experience supporting clients to create successful growth strategies and to identify and implement operational improvements across channels, geographies, and markets. She has worked with firms ranging from the top pharmaceutical companies to biotech startups.

Isabelle is a published author and regular conference speaker. She has broad experience in market access considerations, medical affairs excellence, medical information, customer engagement, digitalization, data husbandry and data analytics and in supporting global transformation programmes.

Prior to consulting Isabelle worked in the pharmaceutical industry, as a clinician and in basic research at the National Institutes of Health.  Outside of work, Isabelle loves the outdoors and is an avid cyclist. She earned her MD and DAS in pharmaceutical medicine from the University of Basel.

Peter is Head of Data & Analytics at the Novartis Foundation, accelerating the use of data and analytics towards the Foundation’s mission to improve population health and inequities. Before that, Peter co-founded Novartis AG’s transformational data42 program which enables the use of the company’s deep pre-clinical, clinical, and real world data to accelerate and improve drug R&D. Prior to his work at Novartis, Peter was Chief Data & Technology Officer at the Institute for Health Metrics and Evaluation (IHME) at the University of Washington in Seattle. He managed the data for the Global Burden of Disease (GBD) study and created IHME’s global public data catalog Global Health Data Exchange (GHDx) and innovative interactive data visualizations. Peter holds an International MBA from Temple University and a Master in Business & Engineering from the Karlsruhe Institute of Technology (KIT).

I am the Vice President elect of MILE (Medical Information Leaders in Europe) and the Global Lead for Medical Information & Communications at Recordati Rare Diseases. I have over 15 years of international experience in shaping medical affairs and customer strategy in the pharmaceutical and biotech industries.

I enjoy designing and implementing high performing organizations that leverage technology, artificial intelligence, and data to deliver high-quality and customer-focused services. My mission within medical information and communications, is to better support & meet the complex informational needs of HCPs and to arm patients with trusted information they can use to manage their complex health conditions. I am also passionate about expanding MILE, a pan-pharmaceutical company coalition, that shapes industry best practices, builds future-facing technology to empower patients and healthcare professionals in accessing robust medical information, and enhancing educational opportunities for professionals in the European Medical Information community.

I am a prolific public speaker, a Coca Cola Scholar, a scientific board member for multiple tech firms, and a freelance consultant for M&A projects.

Jeanne Kehren graduated from the Maisons-Alfort Veterinary School and holds a master in Virology from Pasteur Institute and a PhD in Immunology from the Paris 7 University. Jeanne started her career at Novartis, where she worked in different R&D roles and drove the integration of innovative technologies in drug development. She also fostered the integration of large-scale data in pre-clinical and clinical investigations and developed biomarker and stratification approaches across different disease areas. She joined Sanofi in 2009 as Project Director and held successive positions in Product Development across different therapeutic areas, bringing together Commercial, R&D and Industrial Affairs teams on some major development projects. After joining the Global Strategic Development group in charge of products and Franchise investment strategies, she took the lead of the Early Assets group for Diabetes & Cardiovascular and Primary Care working on the reshaping of the portfolio and the development of new businesses. Jeanne joined Bayer in 2019 heading Digital & Commercial Innovation. Since February 2021 she serves, in addition to her previous role, as Chief Information Officer Pharmaceuticals. In this role she has been driving toward a more impactful and financially sustainable use of technologies supporting the entire Pharma value chain.

Felix is a trained tenor with international stage experience and initiator of the Long Covid project MEA (Music, Emotion, and Respiration) in Switzerland, where he explores the therapeutic potential of music in overcoming health challenges. With his background in emergency medicine as a paramedic and as a neuroscientist (King’s College London), he offers a holistic perspective on health, prevention and aftercare.
As a dynamic speaker, trainer and educator, he shares his insights with audiences in both corporate and educational settings, as well as health conferences. His presentations cover various topics including the intricacies of the brain, impact of healthy breathing, health promotion and effective prevention strategies.

He currently works as Medical and Scientific Director at Scanderra GmbH in Basel, Switzerland.

 
Visit us at the Health Summit to talk to Felix Strobl and discover the harmonious combination of art, science and health.

Julie is a champion of partnerships and innovation within and outside of the health and life sciences industry that she has served for over 25 years.  Currently, with Novartis, her leadership experience spans strategy, consulting, business development, marketing, market access, planning, operations, and digital solution development and transformation. Throughout the course of her career, she has created startups, secured innovative partnerships, launched new business models, developed digital health solutions, and led large-scale commercial implementations. She currently serves as a venture partner, expert advisor, and mentor for startups and accelerators in Switzerland, Europe, and the US. Julie earned an MBA in finance from Wharton/UPenn, and a B.S. in Neuroscience from New York University. She speaks four languages, and has lived and worked across the globe.

Gian-Reto Grond is a digitalisation expert in the Digital Transformation and Steering Directorate of the Federal Office of Public Health (FOPH). He is responsible for the stakeholder management relating to the activities managed by the FOPH in connection with digital transformation in the healthcare sector.
Until December 31,.2023, Gian-Reto Grond was Head of the Digital Health Section at the FOPH. In this function, he was responsible for the electronic patient record (EPR) since 2021, in charge of the legislation with regard to the EPR and in particular of the two revisions of the Federal Act on the Electronic Patient Record (EPRA). Before joining the FOPH in 2017 for the introduction of the EPR, the graduate business economist HWV worked for a major bank in various areas of the financial services sector for around 25 years. Until 2017, as product manager with a major telecom-provider, he was responsible for a service for the digitalised identification and issuing of signatures used by the financial sector. In 2015, he specialised in the field of “eHealth” with an MBA in healthcare.

Dr Gyles Morrison MBBS MSc is a Clinical UX Strategist at Whitespace with a 12 year history in healthcare. Starting as a doctor in the UK, he now focuses on the experiences clinicians and patients have with healthcare technology and services. His areas of interest are digital therapeutics, healthcare behaviour change, and health equality. He has extensive experience with UX strategy, UX maturity and professional development of UX professionals.

Lisa Falco, PhD, is Lead Consultant for AI & Data at Zühlke. She has 15+ years of industry experience in machine learning for healthcare and has led the development of several AI based medical device products. She combines a solid know-how in AI with a passion for building user centric products, especially within the domain of healthcare and women’s health. Furthermore, she is the author of: “Go Figure! The astonishing science of the female body.” and a Forbes contributor on the topics of women’s health and FemTech.

Dr. Samantha Paoletti is enabling collaborative innovation in the Life Sciences and the Healthcare domains.

Working as co-Head of Research and Business Development for Life Science Technologies at CSEM, she is responsible for identifying market needs and for the strategic planning of internal activities towards specific industrial requests.

Samantha has a strong interest and passion for personalized medicine and the development of novel technologies for a precise, robust, and accessible healthcare. Samantha is a diversity and inclusion advocate promoting gender equity in business and healthcare.

James has worked in healthcare innovation for more than a decade. As a dual qualified medic and engineer he has a unique perspective on the challenges faced by both health systems and healthtech organisations. Though working developing strategy for healthcare regions and having developed digital health solutions himself he understands the challenges faced in deploying digitised healthcare at scale and currently advises organisations on how to develop, deploy and scale digital healthcare products.

Dr. Quy Vo-Reinhard, an experienced director and visionary serial entrepreneur in Life Sciences, Healthcare, Blockchain, and Digital Transformation, is deeply committed to fostering innovation and empowering individuals. She is the co-founder and Chief Research Officer of dHealth (Switzerland), the leading blockchain infrastructure for healthcare industry players. Additionally, as the Founding Partner/CEO of V-Space Global (France), Quy drives the creation of an AI-based platform dedicated to nurturing innovation talents.

With over 20 years of industry experience and a PhD in Technology Adoption in Healthcare, Christine is a seasoned healthcare executive that held several leading international positions in major Pharma companies such as Roche and Novartis. Her career encompassed several Digital Strategy roles, where her aim was to help her stakeholders to adopt creative and innovative user engagement strategies, successfully connecting with their key stakeholders to create relevant and sustainable eHealth solutions and implementation strategies.
Her research and consulting work focuses on Healthcare Technology adoption and implementation, looking into the social, organizational, and technical factors impacting user acceptance of novel digital health tools. She led several research projects involving Pharma, eHealth start-ups, and diverse clinics and hospitals across Europe.

Holds a degree in Information Systems with a focus on Healthcare Information Technology from Boston College. Her career began in Boston as a technology consultant at Deloitte collaborating with hospitals and public health departments to implement tech solutions. After Deloitte she joined ZS Associates in Los Angeles and then Zurich to deliver business intelligence solutions to leading pharmaceutical companies. She is also an accomplished panelist and speaker sharing insights on implementing advanced analytics in healthcare.

Ventsislav Dobrev is a pharmacist by training with specializations in Digital Health, Health Informatics and Population Health. Having more than 20 years of experience in healthcare across different domains. Feeling passionate about how technology can empower patients for self-care.

Samantha Gordine is a passionate environmental scientist by training, now working as a sustainability professional in the healthcare sector. She completed her PhD in Marine Biology at the University of St Andrews in 2017 and was shortlisted for a Fulbright scholarship in 2018. Since starting her career, Samantha worked across sectors in academia, the non-profit sector and in the life science industry. Upon moving to Switzerland, she joined the boutique healthcare consulting firm, Arcondis, as a consultant and business developer. She is now establishing and developing Arcondis sustainability solutions portfolio both as a Principal Sustainability Consultant and Sustainability Solution Lead.  As part of her current work, Samantha works with major pharmaceutical companies, non-profits, HCOs and other healthcare-related organisations to develop sustainable product lifecycles, make labs more sustainable and drive research for one health outcomes.
Knowing the challenges our world faces, Samantha is driven to help people make the right choices.  She is interested in a range of topics such as global health, sustainability, climate change and wildlife crime. Although these topics may seem broad and unrelated, Samantha’s work aims to connect them as elements of the same picture – a healthy planet. This fuels her professional interest in the societal and business-related developments concerning the health of people and the environment.

Alessandro Paoli is a dynamic and goal-focused Executive, boasting 20 years of extensive experience in the Insurance and Management Consulting sectors.
He has a proven ability to drive operational transformations on a global scale, having worked across three continents with leading organizations like Allianz, Zurich, McKinsey & Company, and Zurich Internal Consulting.

Currently he is heading Sales in EMEA and Global Partnerships for Zurich LiveWell Services and Solutions.

As the director of healthcare innovation at DayOne, I am deeply immersed in the world of healthtech, digital health, and patient-centricity. My journey in healthcare innovation began from a unique perspective – as a person living with a chronic medical condition. This personal experience ignited my passion for driving change in healthcare technology from within the hospital walls and fuels my dedication to improving healthcare outcomes.
Throughout my career, I have been privileged to contribute to cutting-edge research in medical technology, from academia to the dynamic environment of the med-tech industry and fast-paced startup ecosystem. My approach has consistently centered around bringing together diverse stakeholders to address complex healthcare challenges.
Now, as the director of DayOne, I leverage my multifaceted experience to lead meaningful change in healthcare technology. My goal is to collaborate with like-minded individuals who share my passion for improving the lives of those living with chronic conditions and beyond.

Cécile Tardy-Srinivasan leads the DayOne Health 4.0 Accelerator and supports international health tech startups to scale up at the interface with biopharma companies. Passionate about advancing healthcare, her focus is on building bridges between the patients, clinicians, startups, and Pharma worlds to enable collaborations.

Previously, Cécile worked at major pharma companies, like Novartis, and brings a background in finance from working at EY. Striving to improve patients experience and outcomes, she specialized in co-creating solutions for patients and healthcare professionals, working with different stakeholders in the healthcare ecosystem.

Curious to know more about DayOne Health 4.0? More information available on https://www.dayone.swiss/dayone-accelerator/health-4-0/ 

Caoimhe is currently the Director of Strategy for DayOne, focusing on supporting the growth of the initiative to meet the evolving needs of healthtech startups. She is also the Master of Disaster, responsible for BOOM. An experienced pharmaceutical executive, Caoimhe Vallely-Gilroy is an industry focused clinical strategy specialist and has a background in clinical development and digital health, from managing clinical trials, companion diagnostic development, to ethical oversight, regulatory affairs and, data and digital business model development.
She has previously worked on various position papers with the World Economic Forum to showcase genomic testing as standard of care and the implementation of technology in healthcare, and has been named one of Intelligent Health’s Top 55 innovators in Healthcare in both 2022 and 2023.

Mr. Clayton Hamilton is the Regional Technical Officer for Data and Digital Health within the WHO Regional Office for Europe’s Division for Country Health Policies and Systems, providing qualified support and guidance on all aspects of digital transformation in the context of strengthening and reforming health systems of the Region’s 53 Member States.

With a background in ICT development and business management and over 26 years of UN experience working in the fields of technology, digital health, and public health, Mr. Hamilton provides strategic guidance to assist countries in their development and implementation of national digital health programmes within the framework of delivering on The European Work Programme (2020-2025) ‘United Action for Better Health’, WHO’s triple billion targets, and working towards the achievement of the UN Agenda for Sustainable Development.

In working to accelerate the uptake of safe, equitable and inclusive digital health services for all, Mr. Hamilton leads the development of dialogue and regional guidance development on digital health, establishes partnerships with major international stakeholders working to reform health systems and public health, and provides thought leadership on the adoption of frontier digital technologies to improve access to healthcare and empower individuals in their choices for better health and well-being.

Naomi is a trained medical doctor, public health/health systems and policy specialist. Her professional experiences are at the nexus of understanding and providing innovative solutions to global health system issues – in relation to governance, reform, and collaboration/strategic partnerships in healthcare systems. She has held various roles in European organizations, including with the Association of Schools of Public Health in the European Region (ASPHER), and the WHO Regional Office for Europe (WHO Europe). In her current role as Head of Medical with Mobility/Medical goes Additive e.v. (MGA), she promotes collaboration, builds bridges and strategic partnerships in medical/healthcare additive manufacturing (AM) for the joint development of innovative products, targeted know-how and knowledge transfer – with a focus on a user/patient-driven approach, gender considerations and policies to boost AM in healthcare.

Sara leads the research team at Galen Growth along with focusing on data and analytics insights in the USA and Europe.  Galen Growth the is global leader in Digital Health private market intelligence, data and analytics.  Leveraging over 10 years of life sciences experience across both corporate and startups, Sara knows the ecosystem from both the startup perspective and the side of large corporates.

With over 16 years of experience at the confluence of health, sustainability, and deep technology, Dr. Egle B. Thomas has consistently championed the development of innovative solutions. These initiatives have been instrumental in driving significant business outcomes while simultaneously ensuring the growth and sustainability of individuals, teams, and organizations. Her academic background includes a PhD in Biological Sciences from the University of Birmingham and an MBA from Warwick Business School focused of strategy and finance, further enriched by executive education at Harvard Business School, MIT, and other institutions with a focus on Artificial Intelligence. This robust educational foundation has empowered Dr. Thomas to bring her extensive skills to drive impact in the healthcare sector and beyond, guiding clients to excel in the rapidly evolving AI landscape. As the Managing Director of Stratergix GmbH, she has utilized her deep expertise in strategic consulting, coaching, and artificial intelligence, to implement training, consulting and advisory engagements to steer organizations and teams towards achieving tangible business results.

Kaspar Sutter (47) is the elected Head of the Department of Economic, Social and Environmental Affairs of the Canton of Basel-Stadt since 2021, with the specialist fields of economics, of social insurance and social support and of environmental and energy policy. He represents the interests of the Canton within a variety of affiliated organisations, in-cluding: Member of the Board of EuroAirport Basel-Mulhouse and of Port of Switzerland.

Our Moderator Alexander Nathaus is Partner at the strategy consulting firm Porsche Consulting.
His Parent Company, the car manufacturer Porsche, is one of the world’s most profitable and innovative car makers and has been undergoing several critical turnarounds in the last 30 years.

Operational Excellence in the early 90’s to fight off near bankruptcy; Smart Factory transformations since the 2010’s. And nowadays, digital operating models and digital products for exclusive mobility services.

For the last 13 years, Alexander’s responsibility has been to support Porsche to innovate and secure its future amidst extreme competition in the automotive industry.

But also, to use his firsthand practitioner’s experience from the automotive industry to guide and provide proven solutions for his LifeScience clients.

Alexander and his family live in Hamburg and he has degrees from Maastricht University and ESCP business school in Paris.